Answers are grounded in this paper and cite their sources.
Analysis shows low ALDH2 expression correlates with poor prognosis in breast cancer, highlighting its role as a therapeutic target and prognostic biomarker.
This study established and validated a pro-gnostic model for breast cancer based on lipid metabolism-related genes. It revealed that low ALDH2 expression is closely associated with poor prognosis and immunosuppression, suggesting its potential as a prognostic biomarker and therapeutic target in breast cancer.
No takes yet. Share an insight, caveat, or question.
Lu et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: